Steroids push blood sugar up, and if you use insulin, your doses almost certainly need to go up too. A common starting point for people already on insulin is to increase the total daily dose by about 20% to 30%, but the real adjustment depends on which steroid you’re taking, its dose, and when your blood sugar spikes hardest. Steroid-driven hyperglycemia follows a distinct daily pattern that differs from ordinary high blood sugar, and getting the timing and type of insulin adjustment right matters as much as the size of the increase.
Why Steroids Push Blood Sugar Up
Glucocorticoids, the class of steroids most commonly prescribed for inflammation and immune suppression, interfere with glucose metabolism on multiple fronts. They ramp up the liver’s production of glucose, make muscle and fat tissue more resistant to insulin, and impair the ability of the pancreas to compensate by releasing more insulin. The net result is blood sugar levels that climb well above normal, even in people who have never had diabetes before. In people who already have diabetes, the rise can be dramatic.
Steroids can trigger new-onset hyperglycemia in people with no prior diabetes history or cause severely uncontrolled blood sugar in those with established diabetes.1Endocrinology and Metabolism. Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem This is not a minor side effect. For hospitalized patients, steroid-induced hyperglycemia worsens outcomes, including mortality, yet formal treatment guidelines remain surprisingly underdeveloped.2PubMed Central. A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital That gap means much of the practical management falls on you and your clinician working together to adjust doses in real time.
The Afternoon and Evening Spike
One of the most useful things to understand about steroid-induced hyperglycemia is that it doesn’t hit evenly across the day. If you’re taking a morning dose of a medium-acting steroid like prednisolone or prednisone, the worst blood sugar spikes tend to arrive in the afternoon and evening. Continuous glucose monitoring in patients receiving prednisolone for COPD confirmed that hyperglycemia was concentrated in the afternoon and evening hours, and the researchers specifically recommended targeting treatment at that time window.3The Journal of Clinical Endocrinology & Metabolism. Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD
This pattern has a direct implication for insulin strategy. If you simply raise all your doses uniformly, you may overtreated the morning, when blood sugar is closer to normal, while still not covering the afternoon surge. That mismatch increases your risk of hypoglycemia at one end of the day and hyperglycemia at the other. The practical takeaway is that steroid-induced blood sugar changes are not evenly distributed, so your insulin adjustments shouldn’t be either.
How Much More Insulin You Typically Need
The 20% to 30% increase in total daily insulin is a frequently cited starting recommendation for people with pre-existing diabetes who begin steroid therapy.4Endocrinology and Metabolism. Glucocorticoid-Induced Hyperglycemia: A Neglected Problem – Section: MANAGEMENT Think of that as a first move, not a final answer. Some people need far more.
A study of people with type 1 diabetes placed on a short course of prednisone found that the median total daily insulin dose nearly doubled, going from about 0.5 units per kilogram per day to 0.9 units per kilogram per day. Basal rates and bolus doses were increased by an average of 69%, with the range spanning from 30% to 100% depending on the individual. Those increases started roughly six hours after the first prednisone dose and returned to baseline on the evening of the last day of the steroid course.5PubMed Central. Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone – Section: RESULTS That wide range underscores why there’s no single number that works for everyone. Individual insulin sensitivity, the steroid dose, and your existing level of glucose control all shape how much extra insulin you need.
If you’re on a basal-bolus regimen, the bolus insulin generally needs the larger relative increase. A study of hospitalized patients on high-dose steroids found that equal bolus doses at every meal failed to cover the large blood sugar excursions at dinner and bedtime. Starting with higher bolus insulin at lunch and dinner, along with an enhanced correction scale tuned to steroid-related spikes, was more effective as an initial strategy.6PLOS ONE. Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia – Section: Conclusions
Different Steroids Raise Blood Sugar Differently
Not all glucocorticoids are equal when it comes to blood sugar impact. The steroid your doctor prescribes shapes both how high your glucose goes and when it peaks, which matters for choosing the right insulin adjustment.
In a comparison of hospitalized patients receiving different oral or intravenous corticosteroids, dexamethasone and methylprednisolone produced meaningfully higher average blood glucose levels than prednisolone or hydrocortisone. Methylprednisolone was associated with blood glucose roughly 27 mg/dL higher than prednisolone on average, while dexamethasone ran about 20 mg/dL higher than prednisolone across a seven-day period.7PubMed. The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes These differences are large enough to change your insulin plan.
The timing of the spike also varies by steroid. Continuous glucose monitoring has shown that dexamethasone produces one of the most consistent excursion patterns, with glucose peaking around 220 to 225 mg/dL within roughly two hours and then taking 24 to 36 hours to drift back toward baseline. Methylprednisolone produces a more moderate but longer-lasting elevation, peaking around 175 to 185 mg/dL with sustained high levels for several days.8PubMed Central. Multi-Patient Analysis of Steroid-Induced Hyperglycemia in Diabetic Patients Using Continuous Glucose Monitoring – Section: RESULTS If you’re on prednisone, the spike is mainly an afternoon-and-evening problem matching the drug’s medium duration. If you’re on dexamethasone, which is longer-acting, expect elevated blood sugar around the clock for one to two days after each dose.
Prednisolone and prednisone (a prodrug that converts to prednisolone in the body) are probably the most common outpatient steroids. Their intermediate duration means blood sugar often looks reasonable in the morning but climbs steeply by midday. Hydrocortisone, sometimes used as a physiologic replacement rather than a high-dose anti-inflammatory, tends to cause the least blood sugar disruption of the group.
Matching Your Insulin to the Steroid’s Duration
Because intermediate-acting steroids like prednisone peak in the afternoon and wear off overnight, clinicians often use intermediate-acting insulin, specifically NPH, to shadow that curve. A dose of NPH given in the morning alongside the steroid can provide extra insulin coverage that ramps up over four to eight hours, roughly matching when prednisone pushes blood sugar highest, and then fades overnight when the steroid effect weakens. This approach reduces the risk of overnight hypoglycemia that you’d get if you simply raised your long-acting basal insulin uniformly.
For longer-acting steroids like dexamethasone, the strategy shifts. Because the blood sugar elevation persists for a day or more, a flat increase in your basal insulin (glargine, degludec, or a higher pump basal rate) makes more sense than relying on NPH’s peak-and-fade profile. The general principle is to match the insulin’s action profile to the steroid’s glycemic footprint. Your clinician may need to try more than one approach and adjust over several days.
For people with severe blood sugar swings, combining a basal-bolus insulin regimen with correction doses and a continuous glucose monitor is considered the ideal strategy.4Endocrinology and Metabolism. Glucocorticoid-Induced Hyperglycemia: A Neglected Problem – Section: MANAGEMENT
What Happens During Steroid Tapering
One of the riskiest phases of steroid treatment, from a blood sugar standpoint, is the taper. As the steroid dose comes down, your insulin sensitivity recovers, and the extra insulin you added can quickly become too much. Hypoglycemia during a taper is a real and underappreciated danger.
Close monitoring is essential during any steroid taper, and insulin doses should be reduced in step with the steroid reduction.9PubMed Central. Management of Glucocorticoid-Induced Hyperglycemia In practice, many clinicians recommend reducing insulin by roughly the same percentage as the steroid dose reduction, then checking blood sugar frequently and adjusting further. If you were on 60 mg of prednisone and your insulin was increased by 50%, and the prednisone drops to 30 mg, cutting the extra insulin roughly in half is a reasonable starting point, but you still need to check and fine-tune.
A case report of a person with type 1 diabetes managed on an advanced hybrid closed-loop insulin pump during a steroid taper illustrated both the promise and the limitations of automated insulin delivery in this scenario. While the pump’s automatic basal adjustments helped prevent hypoglycemia, the device settings still had to be manually adjusted as insulin sensitivity changed, including tweaking the carbohydrate-to-insulin ratio, extending the active insulin time setting, and using temporary higher glucose targets on the pump.10Springer Nature. Minimal change disease in a patient with type 1 diabetes and Crohn’s disease managed with advanced hybrid closed-loop insulin therapy during corticosteroid treatment Even with the most advanced technology, steroid tapers require active human attention.
Dexamethasone and Chemotherapy
Dexamethasone is widely used as an anti-nausea medication during chemotherapy, and it creates a particularly tricky pattern for insulin users. In a detailed case study tracking 23 chemotherapy cycles using continuous glucose monitoring, a reproducible triphasic pattern emerged after each intravenous dexamethasone dose: blood sugar climbed to a plateau within about three hours, stayed high for around 29 hours, briefly improved, and then rose again before finally trending back to normal on the third day after the dose.11PubMed Central. Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring – Section: Conclusions Knowing that the effect lingers for roughly three days means you need to plan insulin increases that span well beyond the day of chemo itself.
In women receiving dexamethasone as prophylaxis for gynecological chemotherapy, 94% showed elevated glucose levels. Peak readings were highest on treatment day, and the elevated glucose time was highly variable between patients, ranging from no time above target for one person to over 55 hours above target for another. Peak glucose levels occurred predominantly in the afternoon and evening but were also observed throughout the full 24-hour period.12PubMed. Diurnal profile of interstitial glucose following dexamethasone prophylaxis for chemotherapy treatment of gynaecological cancer – Section: RESULTS The variability here is worth stressing: even if two patients receive the same dexamethasone dose on the same chemo protocol, their blood sugar responses can be wildly different. That’s why frequent monitoring and individualized adjustment are so important.
High-Dose Pulse Steroid Therapy
Some conditions, particularly autoimmune and neurological diseases, are treated with very high intravenous steroid “pulses,” often methylprednisolone at 500 to 1000 mg per day for three consecutive days. Even in people without diabetes, these pulses drive blood sugar to concerning levels. In a study of non-diabetic patients receiving pulse methylprednisolone, fasting blood sugar was elevated in 68% of patients after the first pulse, 94% after the second, and 98% after the third, with mean glucose levels climbing higher with each successive dose.13Revista da Associação Médica Brasileira. Glucose disturbances in non-diabetic patients receiving acute treatment with methylprednisolone pulses – Section: Results
For someone with diabetes receiving pulse steroids, the insulin increases can be substantial. The cumulative effect across consecutive days means that the dose you needed on day one of the pulse may be insufficient by day three. Frequent blood sugar checks, ideally every few hours, are the only safe way to keep up. Hospital settings usually manage this with sliding-scale insulin plus an enhanced basal rate, but if you’re receiving pulse therapy as an outpatient, you and your care team need a clear plan for escalation across the multi-day course.
Pregnancy and Antenatal Steroids
Pregnant women at risk of preterm delivery often receive antenatal betamethasone to accelerate fetal lung maturity. For those who already have gestational or type 2 diabetes managed with insulin, this creates a steep and rapid increase in blood sugar. In a prospective study, participants with pre-existing diabetes required insulin intervention within six hours of steroid administration, those with gestational diabetes needed it within 12 to 24 hours, and even participants without prior diabetes needed intervention within 24 to 48 hours.14PubMed Central. Antenatal Corticosteroids and Their Effects on Maternal Glycemic Status: A Prospective Observational Study From an Indian Tertiary Referral Center – Section: Results
The insulin increases needed in this setting can dwarf those seen in other contexts. A prospective cohort study evaluating an intensified insulin escalation protocol after antenatal betamethasone found that the median increase in insulin requirement was 50% on day one, 106% on day two, and 133% on day three, with some individuals needing increases of several hundred percent. These numbers exceeded what earlier institutional protocols had anticipated.15PubMed Central. Proactive Insulin Escalation for Antenatal Betamethasone-Induced Hyperglycaemia in Women With Diabetes: A Prospective Cohort Study If you’re pregnant, on insulin, and about to receive betamethasone, expect your team to monitor blood sugar very closely and increase your insulin aggressively for several days afterward. The hyperglycemia is transient, typically lasting around 72 hours, but it’s intense.
Continuous Glucose Monitoring Makes a Real Difference
Fingerstick blood sugar checks give you snapshots, but steroid-induced hyperglycemia involves sustained elevations and unpredictable variability that snapshots can miss. Continuous glucose monitoring captures the full picture. In a study of patients with dermatologic diseases receiving steroids, those who developed steroid-induced hyperglycemia spent nearly six hours per day above the target glucose range, including an average of about 1.3 hours per day above 250 mg/dL. Glucose variability was also significantly higher in those with steroid-induced blood sugar problems.16PubMed Central. Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases – Section: Results
That kind of data changes how you adjust insulin. If you can see on a CGM that your blood sugar starts climbing at 1 p.m. and doesn’t come down until midnight, you know exactly when to target extra insulin. Without CGM, you’re estimating based on two or three fingersticks and hoping you caught the peaks. If you’re starting a steroid course that will last more than a few days, asking about CGM access is one of the highest-value conversations you can have with your care team.
Post-Transplant Steroid Regimens
Organ transplant recipients often take glucocorticoids as part of lifelong immunosuppression, and the blood sugar effects interact with other immunosuppressive drugs. After liver transplant, up to 30% of recipients develop post-transplant diabetes, driven largely by the combination of steroids and calcineurin inhibitors like tacrolimus. Clinicians generally wait to formally diagnose post-transplant diabetes until steroid and immunosuppressant doses have stabilized and the surgical stress has resolved.17SpringerLink (Diabetes Therapy). Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment For patients who already had diabetes before transplant, the early post-transplant phase can require very high insulin doses that then gradually decrease as steroid doses come down over weeks or months. The key difference from a short steroid course is the timeline: adjustments happen over months, not days, and insulin needs may never fully return to their pre-transplant levels if the immunosuppressive regimen maintains a low-dose steroid indefinitely.
Demographic Differences in Steroid Response
Blood sugar responses to steroids are not uniform across populations. CGM data from patients receiving different steroid types showed that females generally exhibited higher and earlier glucose peaks than males, with the difference most pronounced with dexamethasone. Age played a role too: younger patients showed more dynamic blood sugar excursions with less uniform recovery, while older patients had flatter glucose trajectories and a more stable return to baseline.8PubMed Central. Multi-Patient Analysis of Steroid-Induced Hyperglycemia in Diabetic Patients Using Continuous Glucose Monitoring – Section: RESULTS These patterns suggest that younger women on dexamethasone may need particularly aggressive insulin increases, and that a “one-size-fits-all” percentage bump will underperform for many individuals. Your starting adjustment is a first approximation; the real work is in the monitoring and titration that follows.
Practical Steps to Discuss With Your Clinician
Adjusting insulin around steroids involves enough variables that a simple checklist is more useful than a general principle. Before starting steroids, or as soon as you learn steroids are being added, these are the questions worth raising with whoever manages your insulin:
- Which steroid: Intermediate-acting (prednisone, prednisolone) versus long-acting (dexamethasone) shapes whether you need afternoon-focused insulin coverage or around-the-clock increases.
- Starting dose increase: For most people already on insulin, a 20% to 30% bump is a common initial move, but some people need 50% or more, especially with dexamethasone or high steroid doses.
- Where to add insulin: Extra mealtime insulin at lunch and dinner often matters more than a flat increase in your morning basal, particularly with prednisone-type drugs.
- Monitoring frequency: At minimum, checking before and after the midday and evening meals captures the steroid’s peak effect. CGM, if available, is far more informative.
- Taper plan: Establish ahead of time how insulin doses will come down as the steroid dose is reduced, to avoid hypoglycemia.
- Contact threshold: Agree on a blood sugar number that should trigger a phone call for further adjustment, rather than waiting for your next scheduled appointment.
Steroid-induced hyperglycemia is one of the most common reasons people with diabetes end up needing temporary but dramatic changes to their insulin regimen. The science on exact protocols is thinner than you might expect, and much of the management is still based on expert consensus rather than large randomized trials. That puts a premium on frequent monitoring and a willingness to adjust quickly, rather than waiting days to see whether a single dose change was enough.